Summary & Overview
HCPCS J2470: Injection, Pantoprazole Sodium 40 mg
HCPCS Level II code J2470 denotes the injection of pantoprazole sodium, 40 mg, an intravenous proton pump inhibitor used to manage acid-related conditions in acute and outpatient settings. Nationally, this code is relevant for hospital outpatient departments, emergency care, infusion centers, and clinic administrations where IV acid-suppression therapy is required. Proper coding for injectable drugs affects billing accuracy, clinical documentation, and payer adjudication across commercial and public plans.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for J2470, typical sites of service, and the billing considerations tied to administration of IV pantoprazole. The publication outlines common modifier use cases and payer coverage patterns where available, highlights where input data is not available, and describes how this HCPCS Level II code fits into broader medication administration workflows.
This summary equips billing professionals, revenue cycle staff, and clinical coders with a clear reference on the purpose and application of HCPCS Level II code J2470, and prepares readers to review payer policies, documentation requirements, and site-of-service implications for IV pantoprazole administration.
Billing Code Overview
HCPCS Level II code J2470 represents the injection of pantoprazole sodium, 40 mg. This code is used to report administration of a proton pump inhibitor formulation intended for intravenous use.
Service Type: Injection/Infusion medication administration
Typical Site of Service: Hospital outpatient department, emergency department, infusion center, or clinic
Data not available in the input for associated taxonomies, ICD-10 diagnoses, or related codes.
Clinical & Coding Specifications
Clinical Context
A patient presents to an outpatient infusion center from the emergency department after an acute upper gastrointestinal bleed with suspected peptic ulcer disease. The patient is an adult with persistent hematemesis and melena, requiring intravenous acid suppression while awaiting endoscopy. The physician orders an intravenous proton pump inhibitor and the medication administered is J2470 (injection, pantoprazole sodium, 40 mg). Nursing verifies allergies, obtains IV access, and documents vital signs before and after the push or infusion per facility protocol. The typical workflow includes medication preparation by pharmacy, bedside verification, administration by a registered nurse or licensed clinician, monitoring for adverse reactions, and documentation in the medication administration record. The service commonly occurs in the hospital inpatient ward, observation unit, emergency department, or outpatient infusion center depending on acuity and payer rules. Clinical monitoring focuses on hemodynamic stability and response to acid suppression while definitive diagnosis and therapy (for example, endoscopic intervention) are arranged.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct Procedural Service | When pantoprazole injection is billed separately from another procedural service on the same day that is not normally reported together. |